| Unique ID issued by UMIN | UMIN000046138 |
|---|---|
| Receipt number | R000052664 |
| Scientific Title | A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms |
| Date of disclosure of the study information | 2021/11/25 |
| Last modified on | 2024/03/29 11:17:20 |
A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms
A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms
A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms
A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms
| Japan |
somatic symptoms
| Psychiatry | Nursing |
Others
NO
Examining the effectiveness of remote cognitive behavioral therapy using a video conferencing system for patients with somatic symptoms
Safety,Efficacy
Exploratory
Others
Phase II
MOS 36-Item Short-Form Health Survey Physical component summary
Pre vCBTp
Post vCBTp
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
| Other |
Video-conference based cognitive behavioral therapy for somatic symptoms (6weeks)
| 20 | years-old | <= |
| 65 | years-old | > |
Male and Female
(1) Those who have received a diagnosis of somatic symptom disorder in DSM-5
(2) Patients who are between 20 and 65 years of age at the time of consent.
(3) Patients who have received a written consent of their own free will after receiving sufficient explanation and understanding to participate in this study.
(4) Those who understand cognitive-behavioral therapy and have the mental and physical condition to practice it continuously for at least two months.
(5) Those who have the ability and environment to use the Internet and computers to receive remote cognitive behavioral therapy (vCBT) using a web conference system.
Translated with www.DeepL.com/Translator (free version)
(1) Patients who are complicated by serious mental disorders such as DSM-5 neurocognitive disorder group, psychotic disorder, bipolar disorder, or substance-related disorder, and who are expected to discontinue cognitive behavioral therapy due to worsening of these symptoms.
(2) Patients with mental retardation (referring to assessment scores such as JART-25: Japanese Adult Reading Test-25) or autism spectrum disorder (referring to AQ: Autism Spectrum Index, etc.).
(3) Those who have a serious progressive physical disease that is expected to interrupt the study.
(4) Patients who are judged by the principal investigator or the study psychologist to be inappropriate for the safe conduct of the study.
(5) Persons whose physical symptoms involve litigation or compensation.
Translated with www.DeepL.com/Translator (free version)
12
| 1st name | Eiji |
| Middle name | |
| Last name | Shimizu |
Graduate School of Medicine Chiba University
Research Center for Child Mental Development, Department of Cognitive Behavioral Physiology
260-8670
1-8-1 Inohana,Chuouku,Chiba,Japan
043-226-2027
eiji@faculty.chiba-u.jp
| 1st name | Hideki |
| Middle name | |
| Last name | Nakamura |
Graduate School of Medicine Chiba University
Department of Cognitive Behavioral Physiology
260-8670
1-8-1 Inohana,Chuouku,Chiba,Japan
043-226-2027
cafa4942@chiba-u.jp
Graduate School of Medicine Chiba University
Department of Cognitive Behavioral Physiology
None
Other
Chiba university certified clinical research board
1-8-1 Inohana,Chuouku,Chiba,Japan
043-222-7171
hsp-chibacrc@chiba-u.jp
NO
| 2021 | Year | 11 | Month | 25 | Day |
Unpublished
Completed
| 2021 | Year | 09 | Month | 01 | Day |
| 2021 | Year | 06 | Month | 28 | Day |
| 2021 | Year | 11 | Month | 01 | Day |
| 2023 | Year | 10 | Month | 31 | Day |
| 2021 | Year | 11 | Month | 22 | Day |
| 2024 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052664